August 2023 Neurology Recall: Functional Neurologic Disorders
Neurology® Podcast
00:00
The Economic Argument for Investing in Neurological Pathways
I think the data from the review makes a compelling argument at one level that we should be investing in clinical pathways and academic pathways for these patients. So by showing that these disorders have comparable costs, perhaps cost and excess of those of other chronic neurological disorders, I think that's a pretty compelling economic argument to invest in those pathways. Beyond that, if you're talking about how do we develop cost-effective treatments, well, I think you have to do the research to prove that something's cost-effective.
Transcript
Play full episode
